Detailed Notes on sustained and extended release
A brinzolamide (BRN) formulation incorporating two varieties of PLGA nanoparticles was injected to the subconjunctival Place of normotensive Albino rabbits. The reduction of IOP in equally BRN-loaded PLGA nanoparticle preparations was better than topical BRN suspension by itself for approximately 10d[24]. Other subconjunctival nanoparticle delivery